Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Niger J Clin Pract ; 19(6): 807-810, 2016.
Article in English | MEDLINE | ID: mdl-27811455

ABSTRACT

BACKGROUND: It is known that no specific antifungal agent exists at present for irrigation of infected root canals. QMix 2in1 was investigated to determine whether they could be an alternative for sodium hypochlorite (NaOCl), chlorhexidine gluconate (CHX), and ethylenediaminetetraacetic acid (EDTA). OBJECTIVE: The aim of this in vitro study was to evaluate and compare the antifungal efficacy of QMix 2in1, 5.25% NaOCl, 2% CHX, and 17% EDTA as a final rinse against Candida albicans (C. albicans). MATERIALS AND METHODS: Ninety single-rooted mandibular premolar teeth were randomly divided into four experimental (n = 20) and two control (n = 5) groups. All root canals were instrumented with Mtwo rotary file system using crown-down technique to an apical size 40. Following root canal preparation, teeth were inoculated with C. albicans and incubated for 72 h. Teeth were irrigated with one of the following solutions as a final irrigant: (1) 5.25% NaOCl, (2) 2% CHX, (3) QMix 2in1, and (4) 17% EDTA. Aliquots from the samples were plated on 4% Sabouraud Agar, and colony-forming units were counted. RESULTS: QMix 2in1, 5.25% NaOCl, and 2% CHX were equally effective (P > 0.05) and significantly superior to 17% EDTA in eradicating C. albicans (P < 0.05). CONCLUSION: QMix 2in1 proved to be effective against C. albicans when used as a final rinse. According to the findings of the present study, QMix 2in1 may be recommended as an alternative final rinse solution.


Subject(s)
Anti-Infective Agents, Local/pharmacology , Biguanides/pharmacology , Candida albicans/drug effects , Chlorhexidine/analogs & derivatives , Disinfectants/pharmacology , Polymers/pharmacology , Root Canal Irrigants/pharmacology , Root Canal Preparation/methods , Sodium Hypochlorite/pharmacology , Chlorhexidine/pharmacology , Edetic Acid/pharmacology , Humans , In Vitro Techniques , Random Allocation
4.
Acta Neurol Scand ; 115(5): 325-30, 2007 May.
Article in English | MEDLINE | ID: mdl-17489943

ABSTRACT

BACKGROUND: Tau protein is present in the microtubules of axons. Markers of various types have been used to demonstrate multiple sclerosis (MS) activity and axonal damage. This study aimed to demonstrate the association between cerebrospinal fluid (CSF) tau protein concentrations and clinical prognosis in MS patients. METHODS: We included 45 patients that were diagnosed according to the McDonald's criteria. The control group was made up of 38 patients that had no signs or symptoms related to the primary central nervous system lesion correlated with the patient group. CSF total tau protein was measured using the ELISA method based on the sandwich method with Innogenetics Innotest hTau antigen kit in pg/ml type. RESULTS: In the patient group, the mean CSF total tau protein level was 238.66 +/- 237.44, whereas it was 93.65 +/- 82.14 in the control group. The mean total tau protein was higher in the three clinical forms when compared with the control group and it was statistically significant (P<0.05). CONCLUSIONS: High tau protein level may be an early marker of axonal damage and this marker may be used for monitoring axon preventing therapies in the follow-up.


Subject(s)
Biomarkers/cerebrospinal fluid , Multiple Sclerosis/cerebrospinal fluid , Multiple Sclerosis/diagnosis , tau Proteins/cerebrospinal fluid , Adult , Disease Progression , Early Diagnosis , Enzyme-Linked Immunosorbent Assay , Female , Humans , Male , Predictive Value of Tests , Prognosis
5.
J Chemother ; 17(4): 361-6, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16167513

ABSTRACT

Vancomycin-resistant enterococci (VRE) are a serious challenge for physicians because of the limited treatment options for infections caused by this organism. Prevention of VRE transmission in hospitals requires early detection of infected or colonized patients. Therefore rapid and correct detection of vancomycin resistance is essential. In this study, we use the resazurin microplate method (RMM), which is a modification of the NCCLS and BSAC broth microdilution methods to rapidly determine the susceptibilities of clinical enterococci isolates to vancomycin. The alteration in the RMM was relevant to the final bacterial count. In this method, inoculum that was 10-fold higher than standard methods was used. A total of 80 enterococci, including 11 VRE isolates and 6 vancomycin intermediate isolates, were screened with this modified colorimetric broth microdilution method. After 4 h of incubation 30 microl of 0.01% resazurin solution were added to each well and the plates were reincubated for color change for 5-10 min. The MICs were obtained at the 4th h. The results were in exact agreement with the NCCLS and the BSAC microdilution methods. Absolute and essential agreements were 100% and there were no minor, major or very major errors. In conclusion, this modified colorimetric broth microdilution method can be used as a reliable, easy, cheap and rapid method for early detection of VRE. Moreover, this method has the potential of being used to test the susceptibilities of different bacteria to other antibiotics.


Subject(s)
Enterococcus/drug effects , Enterococcus/growth & development , Oxazines/pharmacology , Vancomycin Resistance , Xanthenes/pharmacology , Colony Count, Microbial , Culture Media, Conditioned , Drug Resistance, Bacterial , Enterococcus/isolation & purification , Humans , Microbial Sensitivity Tests/methods , Probability , Sampling Studies , Sensitivity and Specificity
6.
J Int Med Res ; 32(5): 484-7, 2004.
Article in English | MEDLINE | ID: mdl-15458279

ABSTRACT

We evaluated the ability of CHROMagar Candida to identify Candida species isolated directly from blood cultures. A total of 50 clinical isolates of Candida were incubated at 35 degrees C, and once growth was established, an aliquot of each was plated onto CHROMagar Candida medium. A control specimen was plated directly from Sabouraud's dextrose agar. Following incubation at 30 degrees C, all yeast isolates were identified by colony morphology and colour. We were able to identify all isolates of C. albicans (n = 20), C. tropicalis (n = 14), C. glabrata (n = 6), and C. krusei (n = 5), which were isolated from blood or from control cultures. This study demonstrated that CHROMagar Candida reliably isolated and identified yeast taken directly from blood cultures. We conclude that this rapid and easy method of identifying Candida species will enable clinicians to quickly choose the appropriate antifungal agent. This should decrease patient morbidity and mortality.


Subject(s)
Blood/microbiology , Candida/classification , Candidiasis/diagnosis , Mycological Typing Techniques , Candida/isolation & purification , Cell Culture Techniques/methods , Chromogenic Compounds , Humans
7.
J Chemother ; 16(2): 128-33, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15216945

ABSTRACT

In this study, the effects of acetylsalicylate and ibuprofen at 2, 4 and 8 mM concentration were investigated on ofloxacin, ciprofloxacin, levofloxacin and pefloxacin minimum inhibitory concentrations (MICs) for 14 Salmonella enterica serovar typhimurium clinical isolates, one standard strain (SZH KUEN 557), SH7616 (acr mutant), SH5014 (parent strain of acr mutant) and PP120 (soxRS mutant) strains. All isolates were susceptible to the 4 fluoroquinolones. In the presence of 2, 4 and 8 mM acetylsalicylate and ibuprofen, 2- to 8-fold increases were observed in fluoroquinolone MICs. This rise was higher, especially in the presence of acetylsalicylate. In spite of this rise, none of the MICs were in the range of resistance limits in vitro. Except for a 2-fold increase in levofloxacin MICs, we did not observe any difference in MICs of ofloxacin, ciprofloxacin, and pefloxacin in the presence of 2, 4 and 8 mM acetylsalicylate and ibuprofen for SH7616 and PP120 strains. According to the in vitro results of this study, it can be suggested that use of acetylsalicylate or ibuprofen together with clinical treatment of bacteria, especially bacteria which show intermediate resistance, will cause resistance. However, since clinical data are insufficient, further studies are needed.


Subject(s)
Anti-Bacterial Agents/pharmacology , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Aspirin/pharmacology , Fluoroquinolones/pharmacology , Ibuprofen/pharmacology , Salmonella typhimurium/drug effects , Humans , Microbial Sensitivity Tests , Salmonella typhimurium/classification
8.
Eur J Ophthalmol ; 12(2): 89-93, 2002.
Article in English | MEDLINE | ID: mdl-12022291

ABSTRACT

PURPOSE: Diabetic retinopathy is the most common complication of diabetes mellitus. No single predisposing factor has been identified, and genetic factors may play a role in the development of severe retinopathy. In this study, we investigated the association between diabetic retinopathy and HLA antigens in type 2 diabetes mellitus. METHODS: This study was conducted at the retina unit of the Department of Ophthalmology of Ondokuz Mayis University between October 1999 and March 2000, and included 46 diabetics with non-proliferative retinopathy and 30 with proliferative retinopathy, with 30 nondiabetic controls. HLA class I (A, B, C) antigens were studied by Terasaki's microlymphocytotoxicity test and HLA class II (DR, DQ) typing was carried out using a polymerase chain reaction-sequence specific primer. RESULTS: HLA-DR4 and DQ8 frequencies were higherin patients with non-proliferative retinopathy than those with proliferative retinopathy, and HLA-DR7 frequency was higher in patients with proliferative retinopathy than non-proliferative cases (p<0.05). No significant differences in HLA antigens were found between patient groups and controls. CONCLUSIONS: The differences in HLA antigen frequencies between patients with and without proliferative retinopathy suggest a genetic contribution to diabetic retinopathy.


Subject(s)
Diabetes Mellitus, Type 2/genetics , Diabetic Retinopathy/genetics , Histocompatibility Antigens Class II/analysis , Histocompatibility Antigens Class I/analysis , Cytotoxicity Tests, Immunologic , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/physiopathology , Diabetic Retinopathy/physiopathology , Female , Humans , Male , Middle Aged , Polymerase Chain Reaction
9.
Clin Microbiol Infect ; 8(12): 810-3, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12519356

ABSTRACT

The main objective of this in vitro study was to assess the effects of cefotaxime and ceftriaxone in killing Salmonella typhi in infected human macrophages. Human monocyte-derived macrophages isolated from peripheral blood of human volunteers were cultured in vitro for macrophage differentiation, and subsequently infected with S. typhi strains (a clinical isolate and a standard strain TA-42) at a cell ratio of 10 : 1. MICs of cefotaxime and ceftriaxone were determined by broth microdilution, and the antibiotics were included in the culture medium at one and five times their MIC values. Samples of cell culture medium taken at 0, 3, 6 and 24 h of incubation were cultured for growth of S. typhi on nutrient agar. Gentamicin (10 mg/L) was included in each well except for the control wells, in order to prevent growth of extracellular S. typhi. Both antibiotics showed good in vitro antibacterial effects against S. typhi strains. There were no statistically significant differences between the extracellular and intracellular effects of antibiotics with regard to elimination of the bacteria. Cefotaxime and ceftriaxone are highly effective against extracellular bacterial growth. The results of our in vitro experiments suggest that cefotaxime and ceftriaxone might also be used clinically against susceptible intracellular pathogens such as S. typhi.


Subject(s)
Anti-Bacterial Agents/pharmacology , Cefotaxime/pharmacology , Ceftriaxone/pharmacology , Macrophages/microbiology , Salmonella typhi/drug effects , Anti-Bacterial Agents/therapeutic use , Cefotaxime/therapeutic use , Ceftriaxone/therapeutic use , Humans , Microbial Sensitivity Tests
10.
J Chemother ; 13(1): 43-6, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11233799

ABSTRACT

The purpose of the present study was to evaluate the utility of the E-test in determining the antifungal susceptibility of Candida species. A total of 50 Candida strains, including 34 Candida albicans and 16 non-albicans were isolated from vaginal swab specimens from women suffering from vaginitis. The minimum inhibitory concentrations (MICs) of amphotericin B, fluconazole and ketoconazole were detected by using broth macrodilution and the E-test. When the results of the two tests were compared, the MIC values were considered acceptable if the difference between the two assays was no more than two-fold (+/-1dilution). The acceptable rates were: 84% for amphotericin B, 97% for fluconazole and 78% for ketoconazole. Finally, MICs of C. albicans against the tested antifungal agents were generally lower than for non-albicans strains. These results suggest that the E-test can be used for the determination of MIC values for Candida species isolates.


Subject(s)
Amphotericin B/pharmacology , Antifungal Agents/pharmacology , Candida/drug effects , Fluconazole/pharmacology , Ketoconazole/pharmacology , Candida/growth & development , Candida/isolation & purification , Candidiasis, Vulvovaginal/microbiology , Female , Humans , Microbial Sensitivity Tests/instrumentation , Vagina/microbiology
11.
Eur Surg Res ; 30(6): 433-8, 1998.
Article in English | MEDLINE | ID: mdl-9838237

ABSTRACT

The use of scolocidal solutions in the hepatobiliary system may result in caustic sclerosing cholangitis. In this study, the effectivenes of a biological metabolite of albendazole, albendazole sulfoxide, on scolices and the hepatobiliary system was evaluated. In the in vitro study, it was found that 100 microg/ml albendazole sulfoxide solution had strong scolocidal effect in 15 min. In the in vivo study, two experimental groups, each consisting of 8 rabbits aged 3-4 months and weighing 2,500 +/- 250 g, 100 microg/ml albendazole sulfoxide and normal saline were given into the biliary tract. ALP, GGT, SGOT and SGPT values on days 7, 30 and 60 were not found to be significantly increased compared to preoperative values. Total bilirubin values were high in the working group 7 and 30 days postoperatively and on day 30 in the control group, returning back to normal levels on day 60 in both groups. Histopathological evaluation of the liver parenchyma and the biliary system on day 60 revealed no differences between the groups. Consequently, albendazole sulfoxide solution may be used intraoperatively for scolocidal purposes.


Subject(s)
Albendazole/analogs & derivatives , Anticestodal Agents/pharmacology , Biliary Tract/drug effects , Echinococcosis, Hepatic/drug therapy , Liver/drug effects , Alanine Transaminase/blood , Albendazole/pharmacology , Albendazole/toxicity , Alkaline Phosphatase/blood , Animals , Anticestodal Agents/toxicity , Aspartate Aminotransferases/blood , Biliary Tract/pathology , Biliary Tract/physiopathology , Bilirubin/blood , Cholangitis, Sclerosing/chemically induced , Echinococcosis, Hepatic/parasitology , Echinococcus/drug effects , Humans , In Vitro Techniques , Liver/pathology , Liver/physiopathology , Rabbits , Sheep , Time Factors , gamma-Glutamyltransferase/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...